Jump to content

Phase I/IIa Trial of an Oral Notch Inhibitor (MK 0752) in Co


Recommended Posts

From Presswatch

A similar trial was opened in 2009 in USA to address Breast Cancer.

This material seeks to control stem cell development thereby inhibiting tumor growth.

2 Dec 2009 ... Official Title: A Phase I Study of MK0752, a Notch Inhibitor, in Patients With Metastatic ... Eligibility. About Enrolling. About MK Numbers ...

www.merckcancertrials.com/ctcpub/trialsSummary.do?id... - Cached - Similar


Link to comment
Share on other sites

  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue. By using our forums you agree to our Terms of Use and Privacy Policy.